Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.

OBJECTIVE Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. METHOD Adult outpatients with nonpsychotic major depressive disorder (MDD) (n = 240) were enrolled from July 2007 through February 2008 and treated in an 8-week, open-label trial with the clinician's choice of a selective serotonin reuptake inhibitor at 6 primary care and 9 psychiatric clinical care settings in the National Institute of Mental Health-funded Depression Trials Network. Diagnosis of MDD was determined by the Psychiatric Diagnostic Screening Questionnaire and an MDD checklist based on DSM-IV-TR criteria. Suicidal ideation and behavior are 1 of 9 symptoms of MDD (depressed mood, loss of interest, appetite or weight change, sleep disturbance, reduced concentration or indecisiveness, fatigue or decreased energy, psychomotor agitation or retardation, feelings of worthlessness, or excessive guilt). The newly developed Concise Health Risk Tracking (CHRT) scale was administered both as the CHRT Self-Report (CHRT-SR) and Clinician Rating (CHRT-C) scales. Psychometric evaluations were conducted on both scales. RESULTS The internal consistency (Cronbach α) was .77 for the 7-item CHRT-C and .78 for the 7-item CHRT-SR with a consistent factor structure, and 3 independent factors (current suicidal thoughts and plans, perceived lack of social support, and hopelessness) for both versions. CONCLUSIONS The 7-item CHRT-C and the 7-item CHRT-SR have excellent psychometric properties and can be used to monitor suicidal risk in clinical practice and research settings. Whether either scale will predict suicide attempts or completions in actual practice would require a very large prospective study sample. TRIAL REGISTRATION Clinicaltrials.gov Identifier: NCT00532103.

[1]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[2]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[3]  A. Beck,et al.  Classification of suicidal behaviors. II. Dimensions of suicidal intent. , 1976, Archives of general psychiatry.

[4]  R. Wetzel.  Hopelessness, depression, and suicide intent. , 1976, Archives of general psychiatry.

[5]  J. Levine,et al.  SAFTEE: a technique for the systematic assessment of side effects in clinical trials. , 1986, Psychopharmacology bulletin.

[6]  I. Miller,et al.  The Modified Scale for Suicidal Ideation: reliability and validity. , 1986, Journal of consulting and clinical psychology.

[7]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[8]  S. Kapur,et al.  The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. , 1991, Archives of general psychiatry.

[9]  C. Chiros,et al.  The Positive and Negative Suicide Ideation Inventory: Development and Validation , 1998, Psychological reports.

[10]  Thomas J. Carmody,et al.  The Inventory of Depressive Symptomatology (IDS): Clinician (IDS‐C) and Self‐Report (IDS‐SR) ratings of depressive symptoms , 2000 .

[11]  D. Wilkinson,et al.  Drug induced akathisia, suicidal ideation and its treatment in the elderly , 2001, International journal of geriatric psychiatry.

[12]  M. Zimmerman,et al.  The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. , 2001, Comprehensive psychiatry.

[13]  M. Zimmerman,et al.  A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. , 2001, Archives of general psychiatry.

[14]  D. Healy.  Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors , 2003, Psychotherapy and Psychosomatics.

[15]  M. Liang,et al.  The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. , 2003, Arthritis and rheumatism.

[16]  J. Markowitz,et al.  The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression , 2003, Biological Psychiatry.

[17]  M H Trivedi,et al.  The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation , 2004, Psychological Medicine.

[18]  R. Moynihan.  FDA advisory panel calls for suicide warnings over new antidepressantss , 2004, BMJ : British Medical Journal.

[19]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[20]  A John Rush,et al.  Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects , 2006, Journal of psychiatric practice.

[21]  M. Trivedi,et al.  Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. , 2007, Drug and alcohol dependence.

[22]  Barbara Stanley,et al.  Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. , 2007, The American journal of psychiatry.

[23]  A. Rush,et al.  Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care , 2007, Neuropsychopharmacology.

[24]  N. Ryan,et al.  Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. , 2009, The American journal of psychiatry.

[25]  L. Greenhill,et al.  The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  J. Mundt,et al.  Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology. , 2010, Journal of psychiatric research.